People | February 20, 2022
Resolution Therapeutics strengthens its team with two new appointments
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
These programs are: Herpes simplex virus (HSV) vaccine candidate, Varicella-zoster virus (VZV) vaccine candidate and Checkpoint cancer vaccine.
The agreement also had a permanent safeguard mechanism which can be resorted to in a situation of sudden surge in imports.
Evonik invests in start-up to improve patient recovery after open-chest surgery
New subsidiaries to be established in Malaysia, Taiwan, Singapore, and Hong Kong
Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021
Cysoni is a bionic device that paces the heart with real-time respiratory modulation. The innovation stems from the idea that heart rate increases and decreases with each breath in normal physiology, termed ‘respiratory sinus arrhythmia’ (RSA)
The new centre will comprise a team of 50 highly experienced specialists
New role strengthens Quantori’s global leadership position in data science & digital IT
_256_384.jpg)
The oversubscribed round was led by New York-based HOF Capital and welcomed new investors including Headline, East Ventures, MS&AD Ventures, DG Daiwa Ventures, Pioneer Fund, as well as existing investor Insignia Ventures Partners
Subscribe To Our Newsletter & Stay Updated
